Incorporating Covariates into Measures of Surrogate Paradox Risk
Clinical trials often collect intermediate or surrogate endpoints other than their true endpoint of interest. It is important that the treatment effect on the surrogate endpoint accurately predicts the treatment effect on the true endpoint. There are settings in which the proposed surrogate endpoint...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Stats |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2571-905X/6/1/20 |